Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Immunodiagnostics Market Grown from 2024 to 2025?

There has been substantial growth in the market size of immunodiagnostics in the past few years. The market is projected to increase from $22.88 billion in 2024 to $24.54 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.3%. This growth seen in the historic period is a result of factors such as the rising prevalence of infectious diseases, the surge in autoimmune diseases, cancer detection and monitoring, worldwide spread of infectious diseases, public health endeavors, and screening campaigns.

What Growth Rate Is Anticipated for the Immunodiagnostics Market in the Coming Years?

Expectations are high for a robust expansion in the immunodiagnostics market size over the coming years. A growth trajectory that concludes with a valuation of $33.14 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 7.8% is anticipated. Factors such as readiness and reactions to pandemics, bespoke medicine and biomarker identification, the enhancement of healthcare infrastructure in emergent markets, integration with laboratory data systems and an increasing chronic illness burden power this growth. The forecast period is set to observe significant trends such as multiplexing methods, point-of-care testing (POCT), biomarker discovery and personalized therapy, digital immunodiagnostics advancements, and a shift towards liquid biopsy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Who Are the Leading Companies in the Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

What Are the Key Drivers of the Immunodiagnostics Market?

The surge in infectious diseases is predicted to stimulate growth in the immunodiagnostics market. These diseases are communicable disorders caused by pathogens such as bacteria, fungi, viruses, or parasites. An immunodiagnostic test is typically employed to detect a virus in a blood sample. For instance, data from the Centers for Disease Control and Prevention, a government agency in the United States, revealed that the tuberculosis cases in March 2024 escalated from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. As a result, the escalating incidence of infectious diseases is projected to promote growth in the immunodiagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

What Are the Key Market Segments in the Immunodiagnostics Industry?

The immunodiagnostics market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments, Software And Services

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

What Are the Latest Trends in the Immunodiagnostics Market?

Significant players in the immunodiagnostics market are concentrating on creating innovative solutions, such as the S. pneumoniae antigen immunodiagnostic assay, to assist in the identification of pneumococcal pneumonia infection. This assay is a test utilized for the detection of Streptococcus pneumoniae antigens in bodily fluids, thus helping identify pneumococcal infections. For instance, the Italian biotech firm, DiaSorin S.p.A., launched the LIAISON S. pneumoniae Antigen Immunodiagnostic Assay in September 2024. This test, intended for the qualitative detection of Streptococcus pneumoniae antigens in adult urine samples suspected of pneumococcal pneumonia, provides a high-throughput solution enabling healthcare workers to swiftly diagnose and separate pneumococcal pneumonia from other respiratory diseases. Using LIAISON CLIA analyzers, the test delivers results in a mere 35 minutes, enabling immediate and focused antimicrobial therapy. Moreover, its capability to detect 91 serotypes aids clinical decision-making and promotes effective antibiotic stewardship, creating a substantial breakthrough in the immunodiagnostics sector for community-acquired pneumonia.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

What Are the Key Regional Markets in the Immunodiagnostics Industry?

North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10093

This Report Delivers Insight On:

1. How big is the immunodiagnostics market, and how is it changing globally?

2. Who are the major companies in the immunodiagnostics market, and how are they performing?

3. What are the key opportunities and risks in the immunodiagnostics market right now?

4. Which products or customer segments are growing the most in the immunodiagnostics market?

5. What factors are helping or slowing down the growth of the immunodiagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model